Shattuck Labs Upgraded to Buy Rating by Wall Street Firm
Analysts see growth potential for biotech company's opioid addiction treatment pipeline
Nordea Trims Biogen Stake by 89%
Investment firm reduces holdings in biotech company during Q4 2025
Amylyx Pharmaceuticals' (AMLX) 'Buy' Rating Reiterated at HC Wainwright
Analysts maintain positive outlook on biotech firm's lead drug candidate
Mar. 27, 2026
Stableford Capital II LLC Acquires New Shares in Biogen Inc.
Biotechnology firm sees new institutional investor take stake
Mar. 27, 2026
Biogen Receives $205.31 Average Price Target from Analysts
Biogen stock assigned 'Hold' rating by 28 brokerages covering the company
Mar. 23, 2026
Syros Pharmaceuticals Projected to Post Quarterly Earnings
The biotech company is expected to report earnings on Wednesday, March 25th.
Mar. 23, 2026
Hudson Bay Capital Management Reduces Moderna Stake
Hedge fund cuts position in COVID-19 vaccine maker by 26.7%
Mar. 22, 2026
Sarepta Therapeutics' Outperform Rating Reiterated by Oppenheimer
Analysts maintain positive outlook on biotech company's stock despite recent earnings miss.
Mar. 22, 2026
Wall Street Zen Upgrades Agios Pharmaceuticals to 'Hold'
The biopharmaceutical company's stock rating improved from 'sell' to 'hold' in a new research note.
Mar. 21, 2026
Wall Street Zen Downgrades Monte Rosa Therapeutics to 'Sell'
Analysts cite concerns over the company's financial performance and future prospects.
Mar. 21, 2026
Genflow Biosciences Shares Drop 6.3%
Biotech firm's stock falls amid market volatility
Mar. 20, 2026
Hudson Bay Capital Management Boosts Stake in Vera Therapeutics
Institutional investor increases holdings in biotech company by 47.4% in Q3
Mar. 19, 2026
ClearPoint Neuro Misses Q1 Earnings Expectations
The medical tech company reported a wider-than-expected loss per share for the quarter.
Mar. 19, 2026
Pegasystems Inc. $PEGA Shares Sold by Penn Capital Management Company LLC
Institutional investor decreased stake in technology company
Mar. 19, 2026
Syros Pharmaceuticals Stock Price Rises Above 50-Day Average
The biotech company's shares trade higher as it advances its lead cancer drug candidate.
Mar. 17, 2026
HSBC Raises Biogen Price Target to $150
Analysts see potential downside of 18.6% from previous close.
Mar. 17, 2026
Algert Global LLC Boosts Stake in Vera Therapeutics
Institutional investor increases holdings in biotech firm by 15.4% in Q3
Mar. 16, 2026
Shattuck Labs Receives $10 Price Target from Analysts
Biotech firm focused on opioid addiction vaccines sees positive analyst outlook.
Mar. 16, 2026
Relay Therapeutics Sees Unusually Large Options Volume
Shares of the biotech company traded down 0.4% on Monday amid the spike in call options activity.
Mar. 16, 2026
HighVista Strategies Boosts Edgewise Therapeutics Stake
Institutional investor increases holding in biotech firm focused on rare diseases
Mar. 16, 2026
HighVista Strategies Boosts Stake in Agios Pharmaceuticals
Hedge fund increases ownership in biopharmaceutical company by 178.5%
Mar. 16, 2026
Gotham Asset Management Boosts Biogen Stake by 65%
Institutional investor now owns over 270,000 shares of the biotech company.
Mar. 16, 2026
Granahan Investment Management Trims Edgewise Therapeutics Holdings
Mutual fund reduces stake in biotech company by 16.2% in Q3
We keep track of fun holidays and special moments on the cultural calendar — giving you exciting activities, deals, local events, brand promotions, and other exciting ways to celebrate.
